Page 320 - Programme book for The International Liver Congress 2015, EASL ILC 2015
P. 320
Autoimmune and Hepato Biliary Disease (Cont.)
P1163 BASELINE LIVER BIOPSY IN AUTOIMMUNE HEPATITIS
(AIH): CONTRIBUTION TO DIAGNOSIS AND PREDICTION
OF TREATMENT RESPONSE
Victoria M. Gordon*, Asha K. Dube, Elaine Mcfarlane,
Mohammed A. Karajeh, Dermot C. Gleeson, The United Kingdom
P1164 IMPAIRED EXPRESSION OF ENZYMES RESPONSIBLE
FOR BILE ACID SYNTHESIS AND DETOXIFICATION IN
PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS
Małgorzata Milkiewicz*, Agnieszka Kempinska-Podhorodecka,
Urszula Wasik, Marta Klak, Malgorzata Blatkiewicz, Piotr Milkiewicz,
Poland
P1165 HIGH SEROPREVALENCE OF HEPATITIS E IN PATIENTS
WITH AUTOIMMUNE HEPATITIS
Michael Eder*, Sandra Beinhardt, Robert Strassl, Albert F. Stättermayer,
Clarissa Freissmuth, Karin Kozbial, Heidemarie Holzmann,
Peter Ferenci, Michael Trauner, Harald Hofer, Austria
ePOSTERS P1166 DECREASED SERUM DNASE1 ACTIVITY IN PATIENTS WITH
AUTOIMMUNE LIVER DISEASES
Nikolaos K. Gatselis*, Aigli G. Vakrakou, Kalliopi Zachou,
Theodoros Androutsakos, Kalliopi Azariadi, Gregorios Hatzis,
Menelaos N. Manoussakis, George N. Dalekos, Greece
P1167 SHARED DISEASE-SUSCEPTIBILITY GENES BETWEEN
PRIMARY BILIARY CIRRHOSIS AND CROHN’S DISEASE IN
THE JAPANESE POPULATION
Yoshihiro Aiba*, Keiko Yamazaki, Nao Nishida, Minae Kawashima,
Yuki Hitomi, Atsumasa Komori, Michiaki Kubo, Katsushi Tokunaga,
Minoru Nakamura, Japan
P1168 PROGNOSTIC CLINICAL BIOMARKERS OF CHOLESTATIC
LIVER INJURY: PERTURBATION OF BILE ACID
METABOLISM AND REACTIVE OXIDATIVE STRESS
MARKER
Noriko Masubuchi*, Masahiro Sugihara, Tomonori Sugita,
Katsushi Amano, Masanori Nakano, Tomokazu Matsuura, Japan
320 The International Liver Congress™ 2015 • ILC Programme
P1163 BASELINE LIVER BIOPSY IN AUTOIMMUNE HEPATITIS
(AIH): CONTRIBUTION TO DIAGNOSIS AND PREDICTION
OF TREATMENT RESPONSE
Victoria M. Gordon*, Asha K. Dube, Elaine Mcfarlane,
Mohammed A. Karajeh, Dermot C. Gleeson, The United Kingdom
P1164 IMPAIRED EXPRESSION OF ENZYMES RESPONSIBLE
FOR BILE ACID SYNTHESIS AND DETOXIFICATION IN
PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS
Małgorzata Milkiewicz*, Agnieszka Kempinska-Podhorodecka,
Urszula Wasik, Marta Klak, Malgorzata Blatkiewicz, Piotr Milkiewicz,
Poland
P1165 HIGH SEROPREVALENCE OF HEPATITIS E IN PATIENTS
WITH AUTOIMMUNE HEPATITIS
Michael Eder*, Sandra Beinhardt, Robert Strassl, Albert F. Stättermayer,
Clarissa Freissmuth, Karin Kozbial, Heidemarie Holzmann,
Peter Ferenci, Michael Trauner, Harald Hofer, Austria
ePOSTERS P1166 DECREASED SERUM DNASE1 ACTIVITY IN PATIENTS WITH
AUTOIMMUNE LIVER DISEASES
Nikolaos K. Gatselis*, Aigli G. Vakrakou, Kalliopi Zachou,
Theodoros Androutsakos, Kalliopi Azariadi, Gregorios Hatzis,
Menelaos N. Manoussakis, George N. Dalekos, Greece
P1167 SHARED DISEASE-SUSCEPTIBILITY GENES BETWEEN
PRIMARY BILIARY CIRRHOSIS AND CROHN’S DISEASE IN
THE JAPANESE POPULATION
Yoshihiro Aiba*, Keiko Yamazaki, Nao Nishida, Minae Kawashima,
Yuki Hitomi, Atsumasa Komori, Michiaki Kubo, Katsushi Tokunaga,
Minoru Nakamura, Japan
P1168 PROGNOSTIC CLINICAL BIOMARKERS OF CHOLESTATIC
LIVER INJURY: PERTURBATION OF BILE ACID
METABOLISM AND REACTIVE OXIDATIVE STRESS
MARKER
Noriko Masubuchi*, Masahiro Sugihara, Tomonori Sugita,
Katsushi Amano, Masanori Nakano, Tomokazu Matsuura, Japan
320 The International Liver Congress™ 2015 • ILC Programme
